Eli Lilly and Company
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2006 | — | — | $3.11B |
| FY2007 | — | — | $3.22B |
| FY2008 | $4.62B | $6.74B | $5.50B |
| FY2009 | $6.63B | $9.53B | $4.46B |
| FY2010 | $6.77B | $12.42B | $5.99B |
| FY2011 | $5.46B | $13.54B | $5.92B |
| FY2012 | $5.52B | $14.77B | $4.02B |
| FY2013 | $4.20B | $17.63B | $3.83B |
| FY2014 | $5.33B | $15.37B | $3.87B |
| FY2015 | $7.97B | $14.57B | $3.67B |
| FY2016 | $8.37B | $14.01B | $4.58B |
| FY2017 | $9.94B | $11.59B | $6.54B |
| FY2018 | $9.20B | $9.83B | $7.32B |
| FY2019 | $13.82B | $2.61B | $2.34B |
| FY2020 | $16.59B | $5.64B | $3.66B |
| FY2021 | $15.35B | $8.98B | $3.82B |
| FY2022 | $14.74B | $10.65B | $2.07B |
| FY2023 | $18.32B | $10.77B | $2.82B |
| FY2024 | $28.53B | $14.27B | $3.27B |
| FY2025 | $40.87B | $26.54B | $7.27B |